Glizamide 60 Tablet contains Gliclazide 60mg, a sulfonylurea class oral antidiabetic agent used to control blood sugar levels in type 2 diabetes patients. It stimulates insulin secretion from pancreatic beta cells to reduce postprandial and fasting glucose effectively.
This tablet belongs to the diabetes care segment, providing an oral therapy that complements diet and lifestyle modifications. Its 60mg dosage is suitable for patients requiring higher or maintenance doses for optimal glycemic control.
Glizamide 60 Tablet is widely prescribed by endocrinologists, general physicians, hospitals, and clinics, making it a high-demand product for PCD pharma franchise and B2B distribution. Its proven clinical efficacy and patient-friendly dosing promote adherence and repeat prescriptions.
For PCD pharma franchise and B2B partners, Glizamide 60 Tablet offers a profitable business opportunity. With steady demand across hospitals, clinics, and retail pharmacies, it is ideal for domestic distribution, export, and third-party manufacturing, ensuring sustainable growth and attractive margins.